Zobrazeno 1 - 10
of 1 399
pro vyhledávání: '"Zara J"'
Autor:
Franklin, Zara J., Lafferty, Ryan A., Flatt, Peter R., McShane, Laura M., O'Harte, Finbarr P.M., Irwin, Nigel
Publikováno v:
In Biochimie August 2022 199:60-67
Autor:
Zara J, Franklin, Ryan A, Lafferty, Peter R, Flatt, Laura M, McShane, Finbarr P M, O'Harte, Nigel, Irwin
Publikováno v:
Biochimie. 199:60-67
Ablation of glucagon receptor (GCGR) signalling is a potential treatment option for diabetes, whilst glucagon-like peptide-1 (GLP-1) receptor agonists are clinically approved for both obesity and diabetes. There is a suggestion that GCGR blockade enh
Autor:
Grover, O., Kocman, J., Odstrcil, M., Odstrcil, T., Matusu, M., Stöckel, J., Svoboda, V., Vondrasek, G., Zara, J.
Publikováno v:
In Fusion Engineering and Design 15 November 2016 112:1038-1044
Publikováno v:
Serbian Journal of Experimental and Clinical Research. 23:155-165
The aim of the study is to evaluate the effect of 4-hydroxy-3,5- di-tertbutyl cinnamic acid on the change in mitochondrial function under conditions of experimental cerebral ischemia in rabbits. The study was performed on 48 male rabbits, which were
Autor:
Luis Fernando Delgadillo-Silva, Anastasia Tsakmaki, Nadeem Akhtar, Zara J. Franklin, Judith Konantz, Gavin A. Bewick, Nikolay Ninov
Publikováno v:
Disease Models & Mechanisms, Vol 12, Iss 1 (2019)
Islet inflammation and cytokine production are implicated in pancreatic β-cell dysfunction and diabetes pathogenesis. However, we lack therapeutics to protect the insulin-producing β-cells from inflammatory damage. Closing this clinical gap require
Externí odkaz:
https://doaj.org/article/7f5ba0f044434aa0811b586038338678
Publikováno v:
In Peptides October 2014 60:95-101
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ryan A Lafferty, Laura M McShane, Zara J Franklin, Peter R Flatt, Finbarr P M O’Harte, Nigel Irwin
Publikováno v:
The Journal of endocrinology. 255(2)
Discerning modification to the amino acid sequence of native glucagon can generate specific glucagon receptor (GCGR) antagonists, that include desHis1Pro4Glu9-glucagon and the acylated form desHis1Pro4Glu9(Lys12PAL)-glucagon. In the current study, we
Publikováno v:
In European Journal of Pharmacology 5 June 2013 709(1-3):43-51
Publikováno v:
IEEE computer graphics and applications [IEEE Comput Graph Appl] 2023 Sep-Oct; Vol. 43 (5), pp. 99-106.